- Home
- ALLK vs INO Comparison
ALLK vs INO Comparison
Compare ALLK & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLK
- INO
- Stock Information
- Founded
- ALLK 2012
- INO 1979
- Country
- ALLK United States
- INO United States
- Employees
- ALLK N/A
- INO N/A
- Industry
- ALLK Biotechnology: Pharmaceutical Preparations
- INO Medical/Dental Instruments
- Sector
- ALLK Health Care
- INO Health Care
- Exchange
- ALLK Nasdaq
- INO Nasdaq
- Market Cap
- ALLK 101.0M
- INO 110.7M
- IPO Year
- ALLK 2018
- INO 1998
- Fundamental
- Price
- ALLK $1.10
- INO $1.87
- Analyst Decision
- ALLK Hold
- INO Buy
- Analyst Count
- ALLK 5
- INO 6
- Target Price
- ALLK $1.67
- INO $16.33
- AVG Volume (30 Days)
- ALLK 306.2K
- INO 1.2M
- Earning Date
- ALLK 11-06-2024
- INO 11-14-2024
- Dividend Yield
- ALLK N/A
- INO N/A
- EPS Growth
- ALLK N/A
- INO N/A
- EPS
- ALLK N/A
- INO N/A
- Revenue
- ALLK N/A
- INO $203,413.00
- Revenue This Year
- ALLK N/A
- INO N/A
- Revenue Next Year
- ALLK N/A
- INO $2,290.97
- P/E Ratio
- ALLK N/A
- INO N/A
- Revenue Growth
- ALLK N/A
- INO N/A
- 52 Week Low
- ALLK $0.54
- INO $1.91
- 52 Week High
- ALLK $3.36
- INO $14.75
- Technical
- Relative Strength Index (RSI)
- ALLK 52.99
- INO 12.71
- Support Level
- ALLK $1.00
- INO $1.91
- Resistance Level
- ALLK $1.11
- INO $4.08
- Average True Range (ATR)
- ALLK 0.08
- INO 0.25
- MACD
- ALLK 0.00
- INO -0.20
- Stochastic Oscillator
- ALLK 47.73
- INO 1.41
About ALLK Allakos Inc.
Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.